Limits...
Development and validation of a severity scale for leprosy type 1 reactions.

Walker SL, Nicholls PG, Butlin CR, Nery JA, Roy HK, Rangel E, Sales AM, Lockwood DN - PLoS Negl Trop Dis (2008)

Bottom Line: Removal of three items from the original scale resulted in better discrimination between disease severity categories.A moderate reaction is a score of between 4.5 and 8.5.A severe reaction is a score of 9 or more.

View Article: PubMed Central - PubMed

Affiliation: Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Steve.Walker@lshtm.ac.uk

ABSTRACT

Objectives: To develop a valid and reliable quantitative measure of leprosy Type 1 reactions.

Methods: A scale was developed from previous scales which had not been validated. The face and content validity were assessed following consultation with recognised experts in the field. The construct validity was determined by applying the scale to patients in Bangladesh and Brazil who had been diagnosed with leprosy Type 1 reaction. An expert categorized each patient's reaction as mild or moderate or severe. Another worker applied the scale. This was done independently. In a subsequent stage of the study the agreement between two observers was assessed.

Results: The scale had good internal consistency demonstrated by a Cronbach's alpha >0.8. Removal of three items from the original scale resulted in better discrimination between disease severity categories. Cut off points for Type 1 reaction severities were determined using Receiver Operating Characteristic curves. A mild Type 1 reaction is characterized using the final scale by a score of 4 or less. A moderate reaction is a score of between 4.5 and 8.5. A severe reaction is a score of 9 or more.

Conclusions: We have developed a valid and reliable tool for quantifying leprosy Type 1 reaction severity and believe this will be a useful tool in research of this condition, in observational and intervention studies, and in the comparison of clinical and laboratory parameters.

Show MeSH

Related in: MedlinePlus

Box plot of the Original Scale Scores by expert severity classification showing medians, interquartile ranges and minimum and maximum scores.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2596969&req=5

pntd-0000351-g002: Box plot of the Original Scale Scores by expert severity classification showing medians, interquartile ranges and minimum and maximum scores.

Mentions: The median scores for each category of reaction severity are shown in the box plots in Fig. 2 with the inter-quartile range (IQR). The median scores for each category were: mild = 5.0 (IQR = 11), moderate = 10.5 (IQR = 13) and severe = 18.0 (IQR = 29).


Development and validation of a severity scale for leprosy type 1 reactions.

Walker SL, Nicholls PG, Butlin CR, Nery JA, Roy HK, Rangel E, Sales AM, Lockwood DN - PLoS Negl Trop Dis (2008)

Box plot of the Original Scale Scores by expert severity classification showing medians, interquartile ranges and minimum and maximum scores.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2596969&req=5

pntd-0000351-g002: Box plot of the Original Scale Scores by expert severity classification showing medians, interquartile ranges and minimum and maximum scores.
Mentions: The median scores for each category of reaction severity are shown in the box plots in Fig. 2 with the inter-quartile range (IQR). The median scores for each category were: mild = 5.0 (IQR = 11), moderate = 10.5 (IQR = 13) and severe = 18.0 (IQR = 29).

Bottom Line: Removal of three items from the original scale resulted in better discrimination between disease severity categories.A moderate reaction is a score of between 4.5 and 8.5.A severe reaction is a score of 9 or more.

View Article: PubMed Central - PubMed

Affiliation: Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Steve.Walker@lshtm.ac.uk

ABSTRACT

Objectives: To develop a valid and reliable quantitative measure of leprosy Type 1 reactions.

Methods: A scale was developed from previous scales which had not been validated. The face and content validity were assessed following consultation with recognised experts in the field. The construct validity was determined by applying the scale to patients in Bangladesh and Brazil who had been diagnosed with leprosy Type 1 reaction. An expert categorized each patient's reaction as mild or moderate or severe. Another worker applied the scale. This was done independently. In a subsequent stage of the study the agreement between two observers was assessed.

Results: The scale had good internal consistency demonstrated by a Cronbach's alpha >0.8. Removal of three items from the original scale resulted in better discrimination between disease severity categories. Cut off points for Type 1 reaction severities were determined using Receiver Operating Characteristic curves. A mild Type 1 reaction is characterized using the final scale by a score of 4 or less. A moderate reaction is a score of between 4.5 and 8.5. A severe reaction is a score of 9 or more.

Conclusions: We have developed a valid and reliable tool for quantifying leprosy Type 1 reaction severity and believe this will be a useful tool in research of this condition, in observational and intervention studies, and in the comparison of clinical and laboratory parameters.

Show MeSH
Related in: MedlinePlus